Neonatal reference intervals for serum steroid hormone concentrations measured by LC-MS/MS.

IF 3.8 2区 医学 Q1 MEDICAL LABORATORY TECHNOLOGY
Anouk Olthof, Jolanda C Naafs, Nitash Zwaveling-Soonawala, Charlotte A Heinen, Sabine E Hannema, Jacquelien J Hillebrand, Anita Boelen, Paul A S van Trotsenburg, Annemieke C Heijboer
{"title":"Neonatal reference intervals for serum steroid hormone concentrations measured by LC-MS/MS.","authors":"Anouk Olthof, Jolanda C Naafs, Nitash Zwaveling-Soonawala, Charlotte A Heinen, Sabine E Hannema, Jacquelien J Hillebrand, Anita Boelen, Paul A S van Trotsenburg, Annemieke C Heijboer","doi":"10.1515/cclm-2024-0393","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>Congenital adrenal hyperplasia (CAH) is a rare, inherited disorder of adrenal steroid synthesis. In many countries it is part of the neonatal screening program enabling early diagnosis and treatment. In case of an abnormal neonatal screening result or when other differences of sexual development (DSD) are suspected, measurement of serum steroid hormones using liquid chromatography coupled to mass spectrometry (LC-MS/MS) is needed for further diagnosis. However, reliable age- and sex-specific reference intervals (RIs) for serum steroid hormones during the neonatal period are missing. We therefore aimed to establish LC-MS/MS based RIs for serum steroid hormones in neonates.</p><p><strong>Methods: </strong>Serum was obtained from healthy term neonates at two time points: 130 samples at day 3-8 (<i>T1</i>, time of the neonatal screening) and 126 samples at day 13-15 (<i>T2,</i> two weeks old). Concentrations of cortisol, cortisone, corticosterone, 11-deoxycortisol, 21-deoxycortisol, 11-deoxycorticosterone, testosterone, androstenedione, and 17-hydroxyprogesterone (17-OHP) were measured using LC-MS/MS.</p><p><strong>Results: </strong>RIs (in nmol/L) were established for <i>T1</i> and <i>T2</i>: cortisone (19.3-215;18.0-212), cortisol (10.0-407;8.4-446), corticosterone (<31;<50), 11-deoxycortisol (0.73-4.6;0.70-3.6), 17-OHP (<4.9;<5.1), androstenedione (0.3-1.8;0.3-2.7), 11-deoxycorticosterone (<0.2;<0.2), and 21-deoxycortisol (<1;<1), respectively. Testosterone differed between boys and girls: RIs at <i>T1</i> and <i>T2</i> for boys were 0.27-4.3 and 0.63-13.9, and for girls<0.30 and <0.47, respectively.</p><p><strong>Conclusions: </strong>We established LC-MS/MS based RIs for cortisol, cortisone, corticosterone, 11-deoxycortisol, 21-deoxycortisol, 11-deoxycorticosterone, testosterone, androstenedione, and 17-OHP in neonates in the first and second week of life.</p>","PeriodicalId":10390,"journal":{"name":"Clinical chemistry and laboratory medicine","volume":" ","pages":""},"PeriodicalIF":3.8000,"publicationDate":"2024-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical chemistry and laboratory medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1515/cclm-2024-0393","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICAL LABORATORY TECHNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives: Congenital adrenal hyperplasia (CAH) is a rare, inherited disorder of adrenal steroid synthesis. In many countries it is part of the neonatal screening program enabling early diagnosis and treatment. In case of an abnormal neonatal screening result or when other differences of sexual development (DSD) are suspected, measurement of serum steroid hormones using liquid chromatography coupled to mass spectrometry (LC-MS/MS) is needed for further diagnosis. However, reliable age- and sex-specific reference intervals (RIs) for serum steroid hormones during the neonatal period are missing. We therefore aimed to establish LC-MS/MS based RIs for serum steroid hormones in neonates.

Methods: Serum was obtained from healthy term neonates at two time points: 130 samples at day 3-8 (T1, time of the neonatal screening) and 126 samples at day 13-15 (T2, two weeks old). Concentrations of cortisol, cortisone, corticosterone, 11-deoxycortisol, 21-deoxycortisol, 11-deoxycorticosterone, testosterone, androstenedione, and 17-hydroxyprogesterone (17-OHP) were measured using LC-MS/MS.

Results: RIs (in nmol/L) were established for T1 and T2: cortisone (19.3-215;18.0-212), cortisol (10.0-407;8.4-446), corticosterone (<31;<50), 11-deoxycortisol (0.73-4.6;0.70-3.6), 17-OHP (<4.9;<5.1), androstenedione (0.3-1.8;0.3-2.7), 11-deoxycorticosterone (<0.2;<0.2), and 21-deoxycortisol (<1;<1), respectively. Testosterone differed between boys and girls: RIs at T1 and T2 for boys were 0.27-4.3 and 0.63-13.9, and for girls<0.30 and <0.47, respectively.

Conclusions: We established LC-MS/MS based RIs for cortisol, cortisone, corticosterone, 11-deoxycortisol, 21-deoxycortisol, 11-deoxycorticosterone, testosterone, androstenedione, and 17-OHP in neonates in the first and second week of life.

通过 LC-MS/MS 测量血清类固醇激素浓度的新生儿参考区间。
目的:先天性肾上腺皮质增生症(CAH)是一种罕见的遗传性肾上腺类固醇合成障碍。在许多国家,先天性肾上腺皮质增生症是新生儿筛查项目的一部分,可实现早期诊断和治疗。如果新生儿筛查结果异常或怀疑存在其他性发育差异(DSD),则需要使用液相色谱-质谱联用技术(LC-MS/MS)测量血清类固醇激素,以便进一步诊断。然而,目前还没有可靠的新生儿期血清类固醇激素年龄和性别特异性参考区间(RIs)。因此,我们旨在建立基于 LC-MS/MS 的新生儿血清类固醇激素参考区间:方法:在两个时间点采集健康足月新生儿的血清:方法: 分两个时间点采集健康足月新生儿的血清:第 3-8 天(T1,新生儿筛查时间)采集 130 份样本,第 13-15 天(T2,两周大)采集 126 份样本。采用 LC-MS/MS测量皮质醇、可的松、皮质酮、11-脱氧皮质醇、21-脱氧皮质醇、11-脱氧皮质酮、睾酮、雄烯二酮和 17-羟孕酮(17-OHP)的浓度:结果:确定了 T1 和 T2 的 RIs(以 nmol/L 为单位):皮质酮(19.3-215;18.0-212)、皮质醇(10.0-407;8.4-446)、皮质酮(T1 和 T2 男孩为 0.27-4.3 和 0.63-13.9,女孩为 0.63-13.9):我们建立了新生儿出生后第一周和第二周的皮质醇、可的松、皮质酮、11-脱氧皮质醇、21-脱氧皮质醇、11-脱氧皮质酮、睾酮、雄二酮和 17-OHP 的 LC-MS/MS RIs。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Clinical chemistry and laboratory medicine
Clinical chemistry and laboratory medicine 医学-医学实验技术
CiteScore
11.30
自引率
16.20%
发文量
306
审稿时长
3 months
期刊介绍: Clinical Chemistry and Laboratory Medicine (CCLM) publishes articles on novel teaching and training methods applicable to laboratory medicine. CCLM welcomes contributions on the progress in fundamental and applied research and cutting-edge clinical laboratory medicine. It is one of the leading journals in the field, with an impact factor over 3. CCLM is issued monthly, and it is published in print and electronically. CCLM is the official journal of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) and publishes regularly EFLM recommendations and news. CCLM is the official journal of the National Societies from Austria (ÖGLMKC); Belgium (RBSLM); Germany (DGKL); Hungary (MLDT); Ireland (ACBI); Italy (SIBioC); Portugal (SPML); and Slovenia (SZKK); and it is affiliated to AACB (Australia) and SFBC (France). Topics: - clinical biochemistry - clinical genomics and molecular biology - clinical haematology and coagulation - clinical immunology and autoimmunity - clinical microbiology - drug monitoring and analysis - evaluation of diagnostic biomarkers - disease-oriented topics (cardiovascular disease, cancer diagnostics, diabetes) - new reagents, instrumentation and technologies - new methodologies - reference materials and methods - reference values and decision limits - quality and safety in laboratory medicine - translational laboratory medicine - clinical metrology Follow @cclm_degruyter on Twitter!
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信